Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.

Asia Pacific Prostate Cancer Conference

1 - 2 Mar 2014

The Portman Ritz Carlton, Shanghai, China

Lecture: PSA Screening - Where East meets West

Dr Liping Xie - Zhejian Medical Univeristy, Zhejian, China

Lecture: PSA Screening - Where East meets West ( Dr Liping Xie - Zhejian Medical Univeristy, Zhejian, China )

Lecture: Current use of systemic therapies in localised disease

Dr Rainy Umbas - University of Indonesia, Jakarta, Indonesia

Lecture: Current use of systemic therapies in localised disease ( Dr Rainy Umbas - University of Indonesia, Jakarta, Indonesia )

Lecture: Current standard of care in advanced disease

Dr Wayne YH Chang - National Yang-Ming University Taipei, Taiwan

Lecture: Current standard of care in advanced disease ( Dr Wayne YH Chang - National Yang-Ming University Taipei, Taiwan )

Lecture: Exploring the androgen signalling pathway in CRPC

Dr Paul de Souza - University of Western Sydney, New South Wales, Australia

Lecture: Exploring the androgen signalling pathway in CRPC ( Dr Paul de Souza - University of Western Sydney, New South Wales, Australia )

Lecture: Clinical perspectives: Non-AR therapeutic targets in CRPC

Dr Kurt Miller - Benjamin Franklin Medical Center, Berlin, Germany;

Lecture: Clinical perspectives: Non-AR therapeutic targets in CRPC ( Dr Kurt Miller - Benjamin Franklin Medical Center, Berlin, Germany; )

Debate: Will chemotherapy continue to be standard treatment for symptomatic...

Dr Paul de Souza - University of Western Sydney, New South Wales, Australia

Debate: Will chemotherapy continue to be standard treatment for symptomatic mCRPC in the era of novel agents? (for) ( Dr Paul de Souza - University of Western Sydney, New South Wales, Australia )

Lecture: Clinical Perspectives: How far are we from personalising treatment for...

Dr Paul de Souza - University of Western Sydney, New South Wales, Australia

Lecture: Clinical Perspectives: How far are we from personalising treatment for prostate cancer patients? ( Dr Paul de Souza - University of Western Sydney, New South Wales, Australia )

Debate: Will chemotherapy continue to be standard treatment for symptomatic...

Dr Kurt Miller - Benjamin Franklin Medical Center, Berlin, Germany

Debate: Will chemotherapy continue to be standard treatment for symptomatic mCRPC in the era of novel agents? (against) ( Dr Kurt Miller - Benjamin Franklin Medical Center, Berlin, Germany )

Lecture: Future strategies and targets for prostate cancer

Dr Kurt Miller - Benjamin Franklin Medical Center Berlin, Germany

Lecture: Future strategies and targets for prostate cancer ( Dr Kurt Miller - Benjamin Franklin Medical Center Berlin, Germany )

Mechanisms of action and robotics in mCRPC

Dr Anthony Ng Chi-Fai - University of Hong Kong, Hong Kong, China

Mechanisms of action and robotics in mCRPC ( Dr Anthony Ng Chi-Fai - University of Hong Kong, Hong Kong, China )

mCRPC management in Taiwan - expert interview

Prof Paul de Souza and Dr Wayne Yen-Hwa Chang

mCRPC management in Taiwan - expert interview ( Prof Paul de Souza and Dr Wayne Yen-Hwa Chang )

Cost constraints affect treatment decision-making in China and Singapore...

Prof Kurt Miller, Dr Li-qun Zhou and Dr Ravindran Kanesvaran

Cost constraints affect treatment decision-making in China and Singapore - expert discussion ( Prof Kurt Miller, Dr Li-qun Zhou and Dr Ravindran Kanesvaran )

Insights into mCRPC in China, Thailand and Indonesia - expert discussion

Prof Rainy Umbas, Prof Narin Voravud and Prof Li Ping Xie

Insights into mCRPC in China, Thailand and Indonesia - expert discussion ( Prof Rainy Umbas, Prof Narin Voravud and Prof Li Ping Xie )

The future of mCRPC treatment - expert discussion

Prof Li Ping Xie - Zhejiang University School of Medicine, Hangzhou, China and...

The future of mCRPC treatment - expert discussion ( Prof Li Ping Xie - Zhejiang University School of Medicine, Hangzhou, China and Prof Paul de Souza - University of Western Sydney, Sydney, Australia )

Sharing Indian perspectives on CRPC

Dr Senthil Rajippa - Kidwai Memorial Institute of Oncology, Bangalore, India

Sharing Indian perspectives on CRPC ( Dr Senthil Rajippa - Kidwai Memorial Institute of Oncology, Bangalore, India )

More from ecancer